- About Us
- Nano-Social Network
- Nano Consulting
- My Account
Mr. LuVerne E.W. Hogg, President and CEO of ZEOX Corporation (The "Company" or "ZEOX") (TSX VENTURE:ZOX) is pleased to announce that the Company has purchased an additional 8% of ZEOX Performance Materials, LLC ("ZPM") from Cheto Partners, LLC, a company controlled by a director of the Company. The acquisition raises ZEOX's interest in ZPM to 59%. The Company paid US$42,814.00 in consideration for the transaction.
Operating from the recently established nanotechnology lab facilities in Tucson, Arizona the business of ZPM is commercialization of new high-tech products utilizing nanostructured materials for coatings, nanoparticle reinforced composites, and nanostructured polymers. Considered new cutting edge business opportunities for the 21st century, nanotechnology involves the engineering of functional systems and products at a molecular level with sizes generally in the range of one-billionth of a meter.
ZPM is currently permitting for the mining of the unique Saponite ("clay") from the Burro Creek, Arizona deposit. ZPM utilizes the unique Saponite clay in the production of polymer nanocomposite for water treatment and rheology control applications. The production of organoclays from the Burro Creek deposit will be based on a combination of new surfactant and process technologies developed by ZPM. The distinctive advantage of ZPM materials over competitive products is in extreme, high-temperatures providing stability and greater overall performance. The new barrier nanocomposite materials are now undergoing commercial pilot-scale testing in partnership with industrial manufacturers.
About ZEOX Corporation
ZEOX is an early stage development company that is engaged in the business of producing, marketing and distributing technological processes and products engineered for the remediation of polluted water, air and soil; the safe disposal of nuclear waste; improved oilfield cementing; and construction applications. ZEOX utilizes the unique attributes of a rare non-metallic industrial mineral known as "chabazite" which is a high purity; high performance industrial mineral.
The Toronto Stock Exchange recently ranked ZEOX as one of their Top 50 companies on the TSX Venture Exchange for 2007 with a 5th place ranking in the mining sector. Management also has the goal of ranking highly in the Clean Environment Industry classification over the next few years.
For a more complete business and financial profile of the Company, management encourages investors to view the Company's documents posted on www.SEDAR.com.
On behalf of the Board of Directors
LuVerne E.W. Hogg, President and Chief Executive Officer
Legal Notice Regarding Forward Looking Statements: This news release contains "forward-looking statements within the meaning of applicable Canadian securities legislation. Forward-looking statements are indicated expectations or intentions. Forward-looking statements in this news release include that the acquisition of ZPM may expand ZEOX's resources and service markets. The Company's products involve detailed scientific knowledge and specific customer adoption criteria, hence factors that could cause actual results to be materially different include that markets may not develop as quickly as anticipated or at all or that mining or productive capacity may not be large enough to handle market demand. Investors are cautioned against placing undue reliance on forward-looking statements.
The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
For more information, please click here
LuVerne E.W. Hogg
(250) 767-6134 (FAX)
Copyright © MarketwireIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Arrowhead Provides Response to New Minority Shareholder Announcement January 7th, 2017
Harris & Harris Group Announces a Proposed Strategic Restructuring December 20th, 2016
New nano approach could cut dose of leading HIV treatment in half February 24th, 2017